Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2005
02/09/2005EP1173621B1 Comparative fluorescence hybridization to oligonucleotide microarrays
02/09/2005EP1150118B1 Cholesterol sensor and method for determining cholesterol
02/09/2005EP1084269A4 Novel peroxidase substrates and their use in catalyzed reporter deposition
02/09/2005EP1060395A4 Microarrays and uses therefor
02/09/2005EP1056860B1 High affinity humanized anti-tag-72 monoclonal antibodies
02/09/2005EP1051427A4 Spoil protein and nucleic acid molecules and uses therefor
02/09/2005EP1017805B1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof
02/09/2005EP0843818B1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
02/09/2005EP0700438B1 Opioid receptors: compositions and methods
02/09/2005CN1578841A Annealing control primer and the use of the same annealing control primer
02/09/2005CN1578840A Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
02/09/2005CN1578838A Method and means for producing protein with prospective post-translation modification
02/09/2005CN1578836A Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
02/09/2005CN1578832A Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants
02/09/2005CN1578789A Hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
02/09/2005CN1578785A Novel immunogenic compositions for the prevention and treatment of meningococcal disease
02/09/2005CN1578673A Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
02/09/2005CN1576840A Methods for diagnosis and therapy of cancer and composition useful therein
02/09/2005CN1576376A Nucleic acid primers of acid alicyclic acid bacterium and method of identifying acid alicyclic acid bacterium
02/09/2005CN1576375A Nucleic acid primers of suberyl alicyclic acid bacterium and method of identifying suberyl alicyclic acid bacterium
02/09/2005CN1576374A Production method and production apparatus of probe carrier
02/09/2005CN1576373A Method for detecting a propensity of an individual to response effectively to treatment of interferon-alpha and ribavirin combined therapy
02/09/2005CN1576372A Polydimethyl Siloxanes sandwich type micro-fluid biological chip
02/09/2005CN1576365A 葡萄糖脱氢酶 Glucose dehydrogenase
02/09/2005CN1576364A Building identification and application for heterogenic interbone marrow filling stem cell transplantation chimeric model
02/09/2005CN1575816A Compounds for the treatment of female sexual dysfunction
02/09/2005CN1188705C Method for determining Prevention ability of blood plasma to poision of diseases
02/09/2005CN1188704C Method For releasing medicament, all composition therein, its use and reagent box
02/09/2005CN1188697C Biological sensor with porous chromatograph diaphragm
02/09/2005CN1188531C Prawn white spot complex virogene diagnostic reagent kit and detecting method thereof
02/09/2005CN1188530C Gene detection reagent kit for SARS virus and detection method
02/09/2005CN1188529C Nano gold mark silver dyeing detection method of gene chip
02/09/2005CN1188528C Intercellular adhesion molecule-3 and its binding ligands
02/09/2005CN1188167C Method of controlling the qualities of attenuated pox vaccine
02/08/2005US6852874 Second cycle asymmetric dihydroxylation reaction
02/08/2005US6852849 Non-oligomerizing tandem fluorescent proteins
02/08/2005US6852845 Non-steroidal anti-inflammatory drugs (NSAIDs); predicting the risk level and or injury type of NSAIDs
02/08/2005US6852839 Fhm, a novel member of the TNF ligand supergene family
02/08/2005US6852837 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis
02/08/2005US6852693 Compositions and methods for promoting lipid mobilization in humans
02/08/2005US6852548 Produce light energy when decomposed; stable at room temperature
02/08/2005US6852546 Diagnosis of autoimmune disease
02/08/2005US6852545 Using pipette comprising piezoelectric/electrostrictive elements for accurate deposition of fluids onto solid support
02/08/2005US6852544 Isotopic labeling; spectroscopy determination
02/08/2005US6852537 Transgenic circulating endothelial cells
02/08/2005US6852528 Human and mouse uroplakin II gene transcriptional regulatory elements
02/08/2005US6852524 Probe carrier, probe fixing carrier and method of manufacturing the same
02/08/2005US6852520 DSP-2 dual-specificity phosphatase
02/08/2005US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6
02/08/2005US6852505 For drug screening/response measurement; adenovirus-2 early region-1A (E1) protein
02/08/2005US6852503 Compositions and methods for utilizing mixed substrate solutions of luminols and dioxetanes
02/08/2005US6852502 Electrochemiluminescent enzyme biosensors
02/08/2005US6852501 Monitoring enzymatic activity in sample; prepare reaction mixture, incubate with sample containing enzyme, mix with solution of molybdate, generate phosphomolybdate complex, expose to hydrophobic surface, measure fluorescence
02/08/2005US6852499 Apparatus with reduced mercaptan odor and improved luminescence at low concentration for detecting luciferase activity
02/08/2005US6852498 Screening efficiency of microbiocides at preventing oomycete infections; obtain sample containing oomycetes, incubate with microbiocide, monitor oomycete response to microbiocide
02/08/2005US6852497 Fusion protein
02/08/2005US6852494 Nucleic acid amplification
02/08/2005US6852493 Amplification of hybridization of nucleic acids; obtain sample, incubate with probe, expose to solid dupport, activate magnetic field, wash support, detect hybridized target nucleotide sequences
02/08/2005US6852492 Apparatus for use in sequencing nucleotide sequences
02/08/2005US6852491 Oligonucleotide primer sets, probes; kits; detecting in test sample Human Immunodeficiency Virus Type 1 (HIV-1)
02/08/2005US6852490 Methods of using an array of pooled probes in genetic analysis
02/08/2005US6852489 Simple and quick method for determining the nucleotide sequence of a mitochondrial 21S ribosomal RNA gene of yeast belonging to Saccharomyces cerevisiae
02/08/2005US6852488 Identifying a base in a nucleic acid
02/08/2005US6852487 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
02/08/2005US6852485 Method for identifying a compound for the treatment of microorganism infections by inhibiting energy storage and utilization in pathogens
02/08/2005US6852484 Contacting Asparagine Synthase polypeptide with test compound; detecting presence or absence of binding between test compound and Asparagine Synthase polypeptide, wherein binding indicates that test compound is candidate for antibiotic
02/08/2005US6852483 Predicting survival of patients with squamous cell carcinoma
02/08/2005US6852320 T cell inhibitory receptor compositions and uses thereof
02/08/2005CA2473458A1 The combination of circulating epstein-barr virus (ebv) dna in the serum or plasma of patients and a method to assess ebv subtypes for the prediction and detection of epstein-barrvirus associated cancers
02/08/2005CA2270227C Detection of antigens via oligonucleotide antibody conjugates
02/08/2005CA2201756C Self-quenching fluorescence probe and method
02/05/2005CA2473337A1 Polymorphisms of the 5' region of the human 5-ht1a gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses
02/03/2005WO2005010794A2 Method for determining metabolic flux affecting substance production
02/03/2005WO2005010521A1 Photonic signal reporting of electrochemical events
02/03/2005WO2005010494A2 Multiplexed analyte detection
02/03/2005WO2005010492A2 Classification of disease states using mass spectrometry data
02/03/2005WO2005010486A2 Biomarker panel for colorectal cancer
02/03/2005WO2005010215A2 Methods for identifying tolerance modulatory compounds and uses therefor
02/03/2005WO2005010213A2 Markers for detection of gastric cancer
02/03/2005WO2005010211A1 Optical detection of analytes by use of semiconductor nanoparticles
02/03/2005WO2005010210A2 Determining the sequence of a polynucleotide
02/03/2005WO2005010209A2 Method for the reverse transcription and/or amplification of nucleic acids
02/03/2005WO2005010208A1 Improved method of amplifying atp and use thereof
02/03/2005WO2005010206A1 Method of evaluating chromosome state and evaluation system
02/03/2005WO2005010205A2 Biomarkers fo aggrecanase activity
02/03/2005WO2005010203A2 Treatment of cells for fluorescence in situ hybridization
02/03/2005WO2005010201A2 Methods and compositions for detecting nucleic acid sequences
02/03/2005WO2005010200A2 Concurrent optimization in selection of primer and capture probe sets for nucleic acid analysis
02/03/2005WO2005010199A2 Invasive cleavage reaction with electrochemical readout
02/03/2005WO2005010186A1 A method for diagnosis of tuberculosis by smear microscopy, culture and polymerase chain reaction using processed clinical samples and kit thereof
02/03/2005WO2005010184A1 Method of detecting mutation
02/03/2005WO2005010183A1 Method of judging risk for onset of drug-induced granulocytopenia
02/03/2005WO2005010181A1 Method for detecting nucleic acid
02/03/2005WO2005010180A1 Method of judging cancer based on the expression of homeobox gene
02/03/2005WO2005010177A1 Non-watson crick base pair-metal complex
02/03/2005WO2005010175A1 Method for producing l-lysine or l-threonine using escherichia bacteria having attnuated malic enzyme activity
02/03/2005WO2005010169A2 High throughput or capillary-based screening for a bioactivity or biomolecule
02/03/2005WO2005010160A2 Liquid crystals with reduced toxicity and applications thereof
02/03/2005WO2005010159A2 Rolling circle amplification of micro-rna samples
02/03/2005WO2005010150A2 Method for in vitro selection of 2’-substituted nucleic acids